SCHEMBL233652

SCHEMBL233652

[CH2]CCCCCCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233534 1.00 DNM1 (0.61)
SCHEMBL3054555 1.00 DNM1 (0.61)
SCHEMBL1948713 1.00 DNM1 (0.61)
SCHEMBL5085490 1.00 DNM1 (0.61)
SCHEMBL2796068 1.00 DNM1 (0.61)
SCHEMBL2031871 1.00 DNM1 (0.61)
SCHEMBL4755739 1.00 DNM1 (0.61)
SCHEMBL4755756 1.00 DNM1 (0.61)
SCHEMBL4754026 1.00 DNM1 (0.61)
SCHEMBL2796425 1.00 DNM1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 710 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4331674-A2 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS University of Miami (US) 2024-03-06 EP claimed
EP-3999095-B1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS UNIV MIAMI (US) 2023-09-13 EP claimed
US-20230174509-A1 THERAPEUTIC USE OF PLEUROMUTILINS ARIVA MED GMBH (AT) 2023-06-08 US claimed
US-RE49481-E1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease HOFFMANN-LA ROCHE INC. (US) 2023-04-04 US claimed
EP-4135683-A1 THERAPEUTIC USE OF PLEUROMUTILINS Nabriva Therapeutics GMBH (AT) 2023-02-22 EP claimed
CN-115413238-A Therapeutic use of pleuromutilin compounds 纳布里瓦治疗有限责任公司 2022-11-29 CN claimed
CN-115368824-A Fast curing migration-free compositions based on organic polymers containing silane groups SIKA技术股份公司 2022-11-22 CN claimed
EP-3999095-A1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS University of Miami (US) 2022-05-25 EP claimed
US-20220143149-A1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2022-05-12 US claimed
US-20210330678-A1 PAPD5 INHIBITORS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-10-28 US claimed
EP-0523965-B1 Salts of N-nitrosophenylhydroxylamine ROHM & HAAS (US) 1996-03-06 EP claimed
EP-0353350-B1 A PROCESS FOR PREPARING N-SUBSTITUTED AMINO ACID ESTERS DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1993-02-17 EP claimed
EP-0523965-A1 Salts of N-nitrosophenylhydroxylamine ROHM AND HAAS COMPANY (US) 1993-01-20 EP claimed
EP-0353350-A1 A process for preparing N-substituted amino acid esters DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1990-02-07 EP claimed
US-4822872-A PREFERENTIAL ADSORPTION OF IMPURITIES ON WATER INSOLUBLE CARRIER WITH AMINE OR ALDEHYDE LIGANDS GREEN CROSS CORPORATION (JP) 1989-04-18 US claimed
EP-0245875-A2 Method of purifying factor VIII GREEN CROSS CORPORATION (JP) 1987-11-19 EP claimed
EP-0230242-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-07-29 EP claimed
EP-0046581-B1 PROCESS FOR SEPARATION OF MUCOPOLYSACCHARIDES Seikagaku Kogyo Co. Ltd. (JP) 1986-01-02 EP claimed
US-4421650-A HYDROPHOBIC INTERACTION CHROMATOGRAPHY SEIKAGAKU KOGYO CO., LTD. (JP) 1983-12-20 US claimed
EP-0046581-A2 Process for separation of mucopolysaccharides Seikagaku Kogyo Co. Ltd. (JP) 1982-03-03 EP claimed